Publications
Corrigendum to ‘Performance of estimated glomerular filtration rate equations across ethnic groups in the AIM CKD UK cohort: a multicentre cross-sectional study’ [The Lancet Regional Health—Europe Volume 69 (2026) 101828]
Gama RM. et al, (2026), Lancet Regional Health Europe, 71
Proteome-Wide Genetic Study Identified ENTPD5 as a Candidate Target for Obesity-Related MASLD.
Wu T. et al, (2026), Obesity (Silver Spring)
Protecting the Kidneys After Replacing the Heart: Another Role for SGLT2 Inhibitors.
Wijayaratne D. and Haynes R., (2026), Circulation
NMR metabolomic profiles in white British and British Indian vegetarians and non-vegetarians in the UK Biobank.
Wang QJ. et al, (2026), Eur J Nutr, 65
Combining quizartinib with intensive chemotherapy for older patients with newly diagnosed AML: results of the UK NCRI AML18 trial.
Knapper S. et al, (2026), Blood, 148, 2327 - 2337
Association between prematurity and cardiac remodelling in childhood: a cross-sectional study.
Kirolos S. et al, (2026), Arch Dis Child
Overview of models for predicting risk of developing ovarian cancer: a systematic review
Ardasheva A. et al, (2026), Communications Medicine
The Changing Face of Clinical Trial Design
Zayed MG. and Armitage J., (2026), British journal of hospital medicine (London, England : 2005)
Making IMPACT (Improving Methodology for Proteinuria and Albuminuria measurement in Clinics and Trials): A Report of the 2025 Proteinuria – Albuminuria Workshop Sponsored by the National Kidney Foundation
HERRINGTON W. et al, (2026), American Journal of Kidney Diseases
Blood Pressure, Kidney Function, and Kidney Mortality Among Mexican Adults.
Zhu D. et al, (2026), Am J Kidney Dis, 88, 725 - 736.e1
Prognostic significance of the magnitude of the white-coat effect in hypertension.
de la Sierra A. et al, (2026), J Hypertens, 44, 1958 - 1965
Adjusting for medication status in genome-wide association studies.
Chong AHW. et al, (2026), PLoS Genet, 22